Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
17. Juli 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 8079
Artikel 1 - 20 / 161578
Exploring copy number alterations (CNAs) to gain new insight into SCLC heterogeneity.
Mol Biol Rep
Galant N, Grenda A, Nico, Krawczyk P.
PMID: 42467275 [PubMed - indexed for MEDLINE]
Stacking Model-Based Preoperative Prediction of Lymphovascular Invasion in Lung Adenocarcinoma by Integrating Intratumoral Heterogeneity Score and Clinicoradiological Features: A Multicenter Study.
Technol Cancer Res Treat
Zhao Y, Zuo Z, Wu Y, Liu W, Qi W, Deng J, Feng Y.
PMID: 42466970 [PubMed - in process]
Evaluation of a CZT-based photon-counting detector CT prototype for low-dose lung cancer screening using patient-specific lung phantoms.
Res Sq
Mei K, Roshkovan L, Halliburton SS, Sharma S, Ross S, Yu Z, Thompson R, Liu LP, Dhanaliwala AH, Litt HI, Noël PB.
PMID: 42466424 [PubMed]
A three-protein serum risk score for predicting immunotherapy response and prognosis in non-small cell lung cancer.
Int J Clin Exp Pathol
Ma Y, Gao Y, Shao C, Wei K, Wang W, Shao Q, Jiang T.
PMID: 42466209 [PubMed]
Long-term efficacy of traditional Chinese medicine combined with chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of reconstructed individual patient data over 3 years.
Front Pharmacol
Guo Y, Wang D, Jia X.
PMID: 42465999 [PubMed]
Preoperative inflammatory and immune-nutritional markers and postoperative pulmonary complications after gastric and colorectal cancer surgery: a systematic review and narrative synthesis.
Front Surg
Zhang H, Zou L, Fang H, Wang H.
PMID: 42465867 [PubMed]
Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review.
Front Oncol
Cabezón-Gutiérrez L, Palka-Kotlowska M, Custodio-Cabello S, Rosero-Rodriguez AC, Chacón-Ovejero B.
PMID: 42465572 [PubMed]
Association between perioperative opioid consumption and postoperative outcomes in lung cancer surgery: evidence from a retrospective study with inflammatory and immune biomarker analysis [Retraction].
Am J Cancer Res
PMID: 42465032 [PubMed]
Application value of next generation sequencing technology for pathogen detection in patients with pulmonary infection and lung cancer.
Am J Cancer Res
Xu L, Liu J, An X, Wu Y, Li X.
PMID: 42465031 [PubMed]
Research progress of EGFR-TKI resistance mechanism and treatment strategy in non-small cell lung cancer.
Am J Cancer Res
Zhai Y, Zhou X, Zhao W, Fan W, Li T, Wang Y, Zhou H, Su F.
PMID: 42465029 [PubMed]
To Study the Correlation Between the Anatomical Variation of Bronchial Vessels Identified by Preoperative Three-Dimensional CT Reconstruction and the Clinical Outcome After Complex Segmentectomy.
Ann Ital Chir
Ma C, Pan J, Liu N.
PMID: 42464837 [PubMed - indexed for MEDLINE]
Cancer risk in patients with nontuberculous mycobacterial pulmonary disease: a nationwide population-based cohort study.
Respir Res
Lee C, Choi HK, Lee HH, Kang YA, Kim EY, Kim HW, Shin N, Park Y.
PMID: 42464269 [PubMed - as supplied by publisher]
Diagnostic and prognostic value of the injury-inflammation-fibrosis serum biomarker panel (KL-6, SAA, YKL-40) in lung cancer treatment-associated ILD.
BMC Pulm Med
Wu S, Jin J, Wu L, Zeng X, Hou Q, Shu L.
PMID: 42464253 [PubMed - as supplied by publisher]
Multiparametric PET/CT Tensor Radiomics for Stability-Aware Machine Learning in Lung Cancer Survival Prediction.
J Imaging Inform Med
Luo M, Harsini S, Rahmim A, Salmanpour MR.
PMID: 42463625 [PubMed - as supplied by publisher]
Survival Outcomes Associated With Short-Acting Versus Long-Acting G-CSF Use During First-Line Chemoimmunotherapy for Advanced Lung Cancer: A Retrospective Study.
Int J Cancer
Xiong Y, Guo W, Ma C, Ren X, Sun Q.
PMID: 42463467 [PubMed - as supplied by publisher]
Choroidal metastasis as the presenting feature of lung chondrosarcoma.
BMJ Case Rep
Pagnacco C, Mudhar HS, Quhill H, Salvi SM.
PMID: 42463174 [PubMed - indexed for MEDLINE]
How hypoxia and mechanics drive lung cancer progression.
Acta Biomater
Kasturi M, Novak CM.
PMID: 42463068 [PubMed - as supplied by publisher]
Evolving Lung Cancer Navigator Practice Through Targeted Professional Development: A Long-term Outcomes Analysis.
Chest
Lloyd SJ, Mortman MF, Monahan PO, Slaven JE, Lemery C, Podsiad M, Barry AM, Weston SA, Boyd AS, Fathi JT.
PMID: 42463006 [PubMed - as supplied by publisher]
A hydrogen sulfide activated fluorescence probe for screening tumor cells and diagnosis of non-small cell lung carcinoma.
J Photochem Photobiol B
Si W, Guo Z, Zhang Y, Meng D, Liu S, Zhang Z, Ma J.
PMID: 42462551 [PubMed - as supplied by publisher]
Exploring decisional needs of adults considering first line treatment for advanced EGFR+ lung cancer: An interpretive descriptive study.
Cancer Treat Res Commun
Seeger R, Stacey D, Bossio E, Wheatley-Price P.
PMID: 42462368 [PubMed - as supplied by publisher]
Artikel 1 - 20 / 161578
Seite 1 von 8079
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung